财经今日头条 > 财经 > 财经要闻

12月14日美股成交前20:中国医药与辉瑞签订新冠药物进口与销售协议

财经要闻 2022-12-15 05:36:48
【12月14日美股成交前20:中国医药与辉瑞签订新冠药物进口与销售协议】周三美股成交额第13名辉瑞公司收高2.66%,成交19.4亿美元。周三中国医药健康产业股份有限公司公告,与辉瑞公司签订协议,将在协议期内负责辉瑞公司新冠病毒治疗药物奈玛特韦片/利托那韦片在中国境内市场的进口和经销。公告显示,协议生效日为2022年12月14日;协议期限为本协议自生效日起生效,直至2023年11月30日止,除非根据本协议之约定提前终止。中国医药将在协议期内负责辉瑞公司新冠病毒治疗药物奈玛特韦片/利托那韦片(Paxlovid)在中国大陆市场的进口和经销。产品的最终使用及销售情况受疫情等因素影响存在较大不确定性。https://cj.sina.com.cn/article/norm_detail?url=https://finance.sina.com.cn/stock/usstock/c/2022-12-15/doc-imxwtanf6404878.shtml","multimedia":{"img_url":["https://n.sinaimg.cn/zhibo/101/w1080h5421/20221215/20d6-091170d223048849165f90f2686f05ed.png"]},"commentid":"live:finance-152-2904669:0","compere_id":0,"creator":"zhangjun@staff.sina.com.cn","mender":"zhangjun@staff.sina.com.cn","create_time":"2022-12-15 05:41:10","update_time":"2022-12-15 05:41:17","is_need_check":"0","check_time":"1970-01-01 08:00:01","check_status":"1","check_user":"","is_delete":0,"top_value":0,"is_focus":0,"source_content_id":"0","anchor_image_url":"","anchor":"直播员","ext":"{"stocks":[{"market":"cn","symbol":"sh600056","key":"u4e2du56fdu533bu836f"},{"market":"us","symbol":"pfe","key":"u8f89u745e"},{"market":"us","symbol":"chhe","key":"u5065u5eb7u4ea7u4e1a"}],"needPush":false,"needAIPush":false,"needCMSLink":true,"needCalender":false,"needProvince":"0","docurl":"https:\/\/finance.sina.com.cn\/7x24\/2022-12-15\/doc-imxwtanf6408146.shtml","docid":"mxwtanf6408146"}","old_live_cid":"0","tab":"","tag":[{"id":"3","name":"公司"},{"id":"4","name":"数据"},{"id":"5","name":"市场"}],"like_nums":0,"comment_list":{"list":[],"total":0,"thread_show":0,"qreply":0,"qreply_show":0,"show":0},"docurl":"https://finance.sina.cn/7x24/2022-12-15/detail-imxwtanf6408146.d.html","rich_text_nick_to_url":[],"rich_text_nick_to_routeUri":[],"compere_info":""},{"id":2904668,"zhibo_id":152,"type":0,"rich_text":"纽交所ARCA钢铁指数收跌0.76%,报1752.36点,美联储主席鲍威尔新闻发布会开始之后曾跌至日低1730.77点。

本文系网络转载,不代表本站立场。

财经今日头条

http://www.cuiru123.com

| 鲁ICP备2021040214号-4

Powered By 财经今日头条

股票

股市行情

炒股入门

股票知识

期货

期货新闻

期货知识

期货行情

财经

财经要闻

观点评论

民生消费

基金

基金动态

基金行情

基金视点